Peter Warendorf

Stock Analyst at Barclays

(4.38)
# 1,277
Out of 5,099 analysts
46
Total ratings
81.5%
Success rate
26.6%
Average return

Stocks Rated by Peter Warendorf

Teladoc Health
Nov 4, 2026
Maintained: Hold
Price Target: $7 → $9
Current: $8.89
Upside: +1.24%
Progyny
Oct 15, 2026
Reiterated: Hold
Price Target: $30
Current: $29.06
Upside: +3.23%
HealthEquity
Sep 18, 2026
Reiterated: Buy
Price Target: $110 → $115
Current: $102.03
Upside: +12.71%
LifeStance Health Group
Sep 10, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $13.37
Upside: +12.19%